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ABSTRACT 
The pathophysiology of major ocular complications in type 2 diabetes mellitus (T2DM) among Bantu is not 
well understood. Several studies have been conducted to determine the basic reasons of visual deficiencies 
(VD) (blindness, visual impairment, and ocular eye diseases) in T2DM among Bantu from Central Africa. The 
quality of dietary intake was assessed in patients along with other ophthalmological assessments for 
diabetic retinopathy, cataract, glaucoma, and macular edema. Beans (Phaseolus vulgaris) and leafy 
vegetables are rich in antioxidants. The consumption of at least 3 ladles per meal, 3 times or more per 
week, has been identified as a potential protective factor against cataract. The anti-radical activity of beans 
is well known in the literature. Beans are considered to have a comparatively higher antioxidant activity 
than in many other vegetables. Our findings from previous epidemiologic studies establish that the 
antioxidant activity of P. vulgaris helps control blood glucose. We, therefore, hypothesize that the dietary 
supplements of bean can be a low-cost prevention approach to reduce cataract and much other visual 
comorbidity associated with T2DM.  However, further epidemiological studies combined with molecular 
research need to be conducted to prove this hypothesis. 
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INTRODUCTION 
Type 2 diabetes mellitus (T2DM) is a lifelong disease, 
which is characterized by high levels of glucose in the 
blood. Worryingly, it is growing at an alarming rate in 
sub-saharan Africa. From the literature, it has been 
elucidated that the major risk factors are westernization, 
sedentary lifestyle, metabolic syndrome (MetS), and 
nutritional transition contributing to overweight (1-3). 
The leading causes of blindness in diabetic patients 
comprise diabetic retinopathy (DR), cataract, glaucoma, 
macular edema, age-related macular degeneration, 
(AMD) and optic nerve atrophy. T2DM is also associated 
with high incidence of risk factors for developing 
cardiovascular disease (CVD) (4-11). An eye survey 
showed that in the US, almost 3.4 million of adults aged 
40 or more were visually disabled and  main causes were 
DR and age-related eye diseases (cataract, AMD, and 
glaucoma) (12). Likewise, DR, cataract, glaucoma, and 
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AMD also appear to be the major causes of blindness in 
ophthalmic practice in Kinshasa, Matadi, Boma, Muanda, 
and Mayombe (MvituMuaka, Unpublished Data). We 
reported 12% cases of DM in Central Africa, which was 
more than that reported in the prior published 
manuscripts. This finding clearly indicates that the 
prevalence of diabetes in this part of world is increased. 
The study showed that the three main causes of 
blindness accounting for 47%, 33%, and 19.8% of cases 
were DR, cataract, and glaucoma, respectively (13). 
  Ample evidence is available confirming that oxidative 
stress increases in patients with T2DM (14,15). Several 
studies in the literature support that the antioxidant rich 
diet-the diet based on beans and vegetables—prevents 
cataract formation by inhibiting the oxidation of lipids 
and proteins in the crystalline lens (16,17).  
  P. vulgaris or bean (Figure 1) is a mass-consumed food 
in Central Africa, and its anti-radical activity, blood 
glucose control property, and weight loss property have 
been substantiated by a growing body of evidence (18-
26). The nutritional composition of bean includes the 
following: trivial fat and an insignificant amount of 
saturated fat, phytate and phenolic compositions (which 
act in the same way as glucose-lowering alpha-
glucosidase or alpha-amylase inhibitors, e.g., metformin 
and acarbose), high folate, Fe, Mg, Zn, omega-3 fatty 
acids, and antioxidants (27-32). It has also been 
elucidated that the antioxidant content of red beans is 
the highest among vegetables (33). 
 
Figure 1. Phaseolus vulgaris (Bean) 
HYPOTHESES 
Considering the evidence which has been discussed, we 
hypothesize that beans can be a cheap and healthy 
dietary supplement to effectively prevent or at least 
retard the progress of cataract and visual comorbidities 
associated with T2DM in diabetic patients.  
 
DISCUSSION  
Among the native populations of Congo, the 
consumption of red beans was considered as a 
preventive measure for metabolic syndrome (34) and 
cataract (35) and other visual impairments. We 
conducted a cross-sectional study in Congo using 244 
patients with T2DM. This was the first African study on 
the prevention of cataract that involved the consumption 
of vegetables rich in antioxidants, in general, and red 
beans, specifically. The result showed an independent 
and protective role of dietary antioxidant-red beans and 
vegetables-against cataract development, and only red 
beans were independent and significantly possible 
protective factors against cataract surgery. Therefore we 
suggested the intake of antioxidant-rich vegetables, 
including red beans (35).  
  In another cross-sectional study conducted among 500 
type 2 diabetic patients in Kinshasa, Africa, we found that 
with regular intake of P. vulgaris (beans), the absolute 
risk of cataract significantly reduced (36).   
  Likewise, a majority of literature suggest that the 
regular intake of antioxidants, e.g., red beans and 
vegetables, precludes cataract development as these 
antioxidants inhibit the oxidation of proteins and lipids 
oxidation (37-39) in the lens.   
 
CONCLUSION 
In conclusion, P. vulgaris might be a cost-effective dietary 
supplement to prevent or stop cataract formation in 
diabetic patients because of its well-known antioxidant 
activity, especially its blood glucose control property. 
However, further  good quality designed epidemiological 
studies combined with molecular research are required 
to explore the molecular details of these properties, 
which may open new horizons with less side effects and 
more cost-effective pharmacologic management of 
cataract. 
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